2023 Form 5500 filing — Kedrion Biopharma, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241011094533NAL0038352112001) for Kedrion Biopharma, Inc. 401(K) Plan, reported by Kedrion Biopharma, Inc. under EIN 38-3841851 and plan number 001. It reports 1,399 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241011094533NAL0038352112001
Filing year
2023
Form type
2
Plan sponsor
Kedrion Biopharma, Inc.
EIN
38-3841851
Plan number
001
Location
Fort Lee, NJ
Participants
1,399
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$32,954,869
Total liabilities (EOY)
$0
Net assets (EOY)
$32,954,869
Employer contributions
$1,442,609
Participant contributions
$2,858,524
Total income / additions
$9,148,188
Benefits paid
$2,768,448
Administrative expenses
$166,149
Total expenses
$2,940,620
Net increase / (decrease)
$6,207,568
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
R-Tech Consultants IncCONTRACT ADMIN$108,267$8,333
Empower Advisory Group, LLCINVESTMENT MGMT$39,294not reported in the loaded dataset
Empower Annuity Insurance CompanyRECORDKEEPER$18,188$0
Qdro Consultants Company, LLCCONSULTING$400not reported in the loaded dataset

Related Form 5500 pages